NCT03363373
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03363373
Title Naxitamab for Neuroblastoma With Osteomedullary Disease
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | ITA | GBR | ESP | DNK | DEU | CAN

Facility Status City State Zip Country Details
Riley Hospital for Children Indianapolis Indiana 46202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
The Hospital for Sick Children Toronto M5G 1X8 Canada Details
Rigshospitalet Copenhagen 2100 Denmark Details
University Medical Center Hamburg-Eppendorf Hamburg Germany Details
Johannes Gutenberg-Universität Mainz Germany Details
University Hospital Regensburg Regensburg Germany Details
Hong Kong Children's Hospital Hong Kong Hong Kong Details
Queen Mary Hospital Hong Kong Hong Kong Details
Tata Memorial Centre Mumbai 400012 India Details
Giannina Gaslini Hospital Genoa Genoa 16147 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milan Milan 20133 Italy Details
Ospedale Pediatrico Bambino Gesù Rome Italy Details
Hospital Sant Joan de Déu Barcelona 08950 Spain Details
Hospital Infantil Universitario Niño Jesús Madrid 28009 Spain Details
Hospital Universitario Virgen Del Rocío Seville Spain Details
Hospital Universitario y Politécnico La Fe Valencia 46026 Spain Details
The Royal Glasgow Children's Hospital Glasgow G51 4TF United Kingdom Details
Leeds General Infirmary Leeds LS1 3EX United Kingdom Details
University Hospital Southampton Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field